In our study, we also showed that decreased ATRX mRNA expression was characteristically enriched in low-grade astrocytomas and this ATRX alteration significantly overlapped with IDH1/2 mutations (P<0.0001). The gene discussed is ATRX; the disease is astrocytoma (excluding glioblastoma).